About Cambridge Epigenetix
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Cambridge, United Kingdom
Year Founded
2012
Team Size
51-100
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
cambridge-epigenetix.com
Domain Registered Date
Oct 31, 2012
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $88,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Series-B+ announced
- Capital Raise
Raised $5,500,000 · Series-A
- Milestone
Website domain registered
cambridge-epigenetix.com
- Milestone
Company founded
Cambridge, United Kingdom
Investors & Backers
Ahren Innovation Capital
DNA Capital
GV
New Science Ventures
Sequoia
Syncona Partners LLP
Temasek
Third Point Ventures
University of Cambridge
University of Cambridge Enterprise
Funding History
Series-B+
· Nov 2, 2021
$88,000,000 fundraisingfox.com
Series-B+
· Mar 14, 2016
Undisclosed Source
Series-A
· Oct 29, 2014
$5,500,000 Source
Founders & Leadership
Bobby Yerramilli-Rao
Founder
Work email & phone locked
Unlock →
Fiona Stewart
Chief Financial Officer
Work email & phone locked
Unlock →
Nathan Williams
DevOps Engineer
Work email & phone locked
Unlock →
Peter Fromen
Chief Executive Officer
Work email & phone locked
Unlock →
Shankar Balasubramian
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026